Trial Profile
Prevention of Recurrent Symptomatic Urinary Tract Infections in Participants With Chronic Neurogenic Bladder Dysfunction: A Mixed Method Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 May 2021
Price :
$35
*
At a glance
- Drugs Escherichia-coli-strains (Primary)
- Indications Escherichia coli infections; Urinary tract infections
- Focus Therapeutic Use
- Acronyms PReSuTINeB
- 03 Nov 2015 New trial record